Titan divests non-core assets, looks to high impact gold drilling campaign

|

Published 24-AUG-2020 10:12 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Freeing it up to focus on its key Ecuadorian assets, Titan Minerals Ltd (ASX:TTM) has come to an agreement to divest of its non-core assets in Peru.

Titan has agreed to dispose of the right to acquire the Coriorcco and Las Antas mineral claims located in Peru, to Western Pacific Resources Corp. (TSX-V: WRP), subject to the satisfaction of certain conditions, and sell the Vista Gold Plant to AC 081 S.A.C, a private investment group with a long history of successful toll milling in Peru.

Titan is to receive total consideration upon completion of the divestment of US$6,440,000, including US$5,150,000 cash. If Western Pacific exercises the option to acquire a 100% interest in the Coriorcco property, Titan will be granted a 1% Net Smelter Return (NSR).

The sale, a part of a strategic review of its consolidated operations, will allow Titan to focus on the development of its flagship Dynasty Gold Project and the Copper Duke Project in Ecuador.

Having recently completed a capital raise, the company continues to revive exploration activity at the Dynasty Gold project and the nearby highly prospective Copper Duke Gold-Copper porphyry project.

Dynasty is an advanced stage exploration project located in the Loja Province of southern Ecuador currently hosting a 2.1Moz Au foreign resource estimate averaging 4.5g/t gold reported in compliance with Canadian NI 43-101 standards.

Titan reported assay results in July for diamond drilling completed at the Dynasty Gold Project that further support an emerging large-scale gold system and extend known mineralisation that remains open in multiple directions and at depth.

The commencement of drilling will be a key catalyst in the near term for better defining mineralisation at Titan’s flagship Dynasty Gold Project.

Commenting on the divestment, Titan Minerals Managing Director, Laurie Marsland said, “Titan’s primary focus remains firmly set on developing the Dynasty Gold Project and the Copper Duke Project in Ecuador. This divestment will support that objective whilst retaining exposure to both the Coriorcco and Las Antas projects.

“The funds received will contribute toward completion of the high impact drilling campaign at the Dynasty Gold Project, the airborne geophysical surveys for high resolution magnetic coverage and significant surface sampling programs, all of which support conversion of the substantial NI 43-101 Resource to a JORC Code compliant Resource in late 2020.”

Titan Geologist logging recent diamond drilling at the flagship Dynasty Gold Project
Titan Geologist logging recent diamond drilling at the flagship Dynasty Gold Project


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X